Written and maintained by CASRAI Editorial Board
Last updated
CPT Category III codes are a temporary set of five-character alphanumeric procedural codes—structured as four digits followed by the letter T (for example, 0042T or 0721T)—maintained by the American Medical Association (AMA) CPT Editorial Panel. Within the broader HCPCS vs. CPT code architecture, Category III codes serve a dedicated scientific and regulatory purpose: allowing health systems, clinical trial sponsors, registries, and payers to track the real-world utilization, safety, and clinical outcomes of emerging medical technologies, services, and procedures before they meet the evidentiary threshold required for a permanent CPT Category I code.
In contemporary biomedical informatics and medical device commercialization, Category III codes have become the primary reimbursement and health-services tracking pathway for Software as a Medical Device (SaMD), quantitative imaging biomarkers, and clinical artificial intelligence algorithms classified under AMA CPT Appendix S.
What Are CPT Category III Codes and How Do They Differ from Category I and Unlisted Codes?
Historically, when a medical device manufacturer or academic medical center introduced a novel diagnostic or therapeutic procedure that lacked a permanent five-digit numeric CPT Category I code, coders had to submit claims using a generic “unlisted procedure” code (such as 76498 for an unlisted magnetic resonance procedure). Because unlisted codes lump dozens of unrelated experimental and emerging procedures into a single bucket, health services researchers and Medicare Administrative Contractors (MACs) could not query administrative claims databases to measure how often a specific new technology was performed or whether it improved patient outcomes.
The AMA established CPT Category III codes to eliminate this blind spot. Under official CPT coding guidelines, three structural rules govern Category III usage:
- Mandatory Reporting Over Unlisted Codes: Whenever a Category III code exists that accurately describes a performed procedure or emerging service, the provider must report the specific Category III code rather than an unlisted Category I code or a nearby Category I code by approximation.
- Lower Evidentiary Threshold at Entry: Unlike Category I codes—which require full FDA clearance or approval (where applicable), widespread performance across multiple U.S. geographic regions, and multiple peer-reviewed U.S. clinical efficacy publications—a Category III code application only requires demonstrating that the procedure or service is currently being evaluated in humans (such as an institutional review board [IRB]-approved clinical trial protocol) or has peer-reviewed literature supporting its clinical relevance.
- No National Relative Value Units (RVUs): The AMA/Specialty Society Relative Value Scale Update Committee (RUC) does not typically assign national work, practice expense, or malpractice RVUs to Category III codes on the Medicare Physician Fee Schedule (MPFS). Instead, payment is contractor-priced (carrier judgment) by regional MACs or commercial payers based on medical necessity documentation or local coverage determinations (LCDs).
| Coding Dimension | CPT Category I Codes | CPT Category III Codes (XXXXT) |
Unlisted CPT Category I Codes |
|---|---|---|---|
| Code Format | 5 numeric digits (e.g., 99214, 71250) |
4 numeric digits + T (e.g., 0523T) |
5 numeric digits ending in 9 or 99 (e.g., 76498) |
| Release Cadence | Annually (effective January 1) | Semi-annually (posted January 1 / July 1; effective 6 months later on July 1 / January 1) | Annually (part of Category I manual) |
| Lifecycle Duration | Permanent until revised or deleted | Temporary: 5-year sunset unless converted to Category I or extended | Permanent catch-all code |
| Medicare Valuation | RUC-surveyed national RVUs on MPFS | Contractor-priced by MACs / OPPS APC assignment where applicable | Manual review of operative/procedure report per claim |
The 5-Year Sunset Rule and Conversion to CPT Category I
Every CPT Category III code carries a built-in five-year sunset period starting from its initial implementation date. The five-year window gives device sponsors, specialty societies, and clinical investigators time to accumulate multi-center utilization volume and publish peer-reviewed U.S. clinical effectiveness studies (often alongside Medicare device coverage pathways such as NCD 310.1, TCET, or CED).
Before the five-year sunset expires, one of three outcomes occurs at the CPT Editorial Panel:
- Conversion to Permanent Category I Status: If the technology has achieved FDA clearance or approval, is performed by multiple practitioners across diverse U.S. clinical sites beyond the original developers, and has demonstrated clinical efficacy in peer-reviewed literature, the Panel converts the service to a permanent 5-digit Category I code and refers it to the RUC for national RVU valuation.
- Formal Extension (Renewal): If clinical trials or regulatory reviews are still actively generating needed utilization data, a specialty society or sponsor may petition the Panel before sunset to extend the Category III code for an additional 5-year tracking cycle.
- Archival (Sunset Deletion): If neither conversion nor renewal is requested or approved, the code is archived at the end of year five and can no longer be billed on administrative claims.
AMA CPT Appendix S: Artificial Intelligence Taxonomy for Category III Codes
Because quantitative imaging software, physiological signal analyzers, and machine learning diagnostic tools account for a rapidly growing share of Category III applications, the AMA introduced CPT Appendix S (Artificial Intelligence Taxonomy for Medical Services and Procedures). Rather than using ambiguous marketing terms, Appendix S classifies algorithmic medical services into three functional tiers according to how the software output interacts with the Qualified Health Care Professional (QHP):
- Assistive (Level I): The machine detects clinically relevant data or highlights features of interest, but does not perform autonomous quantitative analysis or reach a diagnostic conclusion. A physician or QHP must independently interpret the underlying medical data and generate the report.
- Augmentative (Level II): The machine analyzes or quantifies clinical data (such as computing volumetric plaque burden on coronary CT angiography or automated fractional flow reserve metrics) to produce a clinically meaningful derived parameter. However, a physician or QHP is still required to integrate and interpret that output within the clinical report.
- Autonomous (Level III): The machine automatically analyzes the patient data and independently generates a clinically meaningful conclusion, diagnostic decision, or care recommendation without requiring concurrent physician interpretation (for example, autonomous retinal imaging interpretation for diabetic retinopathy).
EHR Charge Capture and Clinical Research Billing Workflows
How do CPT Category III codes integrate with EHR and health informatics workflows? Hospital revenue cycle teams and clinical trial billing offices must configure two technical safeguards:
- Semi-Annual EHR Chargemaster Updates: Unlike Category I codes and ICD-10-CM diagnosis codes, which follow annual update cycles, Category III codes are released twice a year (posted January 1 for July 1 implementation, and posted July 1 for January 1 implementation). EHR charge-router dictionaries must ingest both the January and July AMA files so emerging trial procedures are not rejected at claim scrubbing.
- Clinical Trial Claim Segmentation: When a Category III procedure is performed as part of a qualifying clinical trial or Investigational Device Exemption (IDE) study, research billing compliance systems pair the
XXXXTcode with the appropriate clinical trial claim coding modifiers (Q0for investigational clinical services orQ1for routine clinical services, alongside Condition Code30and the 8-digit ClinicalTrials.gov NCT number) to ensure accurate payer adjudication and prevent duplicate billing.
Frequently Asked Questions
What are CPT Category III codes and how are they used in clinical research and healthcare?
CPT Category III codes are temporary, five-character alphanumeric codes ending in the letter T (four digits plus T, such as 0523T) assigned by the American Medical Association (AMA) CPT Editorial Panel to track emerging technologies, procedures, and services—including novel medical devices and clinical AI algorithms—for health services research, utilization tracking, and payer evidence generation.
What standards or regulatory requirements govern CPT Category III codes?
CPT Category III codes are governed by the AMA CPT Editorial Panel under the HIPAA standard code set rules (45 CFR § 162.1002). They are published semi-annually (effective January 1 and July 1), must be reported instead of an unlisted Category I code whenever a specific Category III descriptor applies, and carry a mandatory 5-year sunset period unless converted to Category I or formally renewed.
How do CPT Category III codes integrate with EHR and health informatics workflows?
In EHR charge-capture and clinical trial billing modules, Category III codes are loaded on a semi-annual release schedule (January 1 and July 1), mapped to AMA Appendix S classifications (Assistive, Augmentative, or Autonomous) for Software as a Medical Device (SaMD) workflows, and linked to clinical trial claim modifiers (such as Q0/Q1 and Condition Code 30) to support Medicare Coverage with Evidence Development (CED) and MAC local coverage determinations.
